145 related articles for article (PubMed ID: 7806590)
1. Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes?
Kerbel RS; Kobayashi H; Graham CH
J Cell Biochem; 1994 Sep; 56(1):37-47. PubMed ID: 7806590
[TBL] [Abstract][Full Text] [Related]
2. Quantitative variations in gene expression: possible role in cellular diversification and tumor progression.
Nicolson GL
J Cell Biochem; 1991 Aug; 46(4):277-83. PubMed ID: 1757473
[TBL] [Abstract][Full Text] [Related]
3. Metastasis-Associated genes and metastatic tumor progression.
Nicolson GL; Moustafa AS
In Vivo; 1998; 12(6):579-88. PubMed ID: 9891220
[TBL] [Abstract][Full Text] [Related]
4. Gene expression, cellular diversification and tumor progression to the metastatic phenotype.
Nicolson GL
Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of metastatic progression.
Wright JA; Egan SE; Greenberg AH
Anticancer Res; 1990; 10(5A):1247-55. PubMed ID: 2241100
[TBL] [Abstract][Full Text] [Related]
7. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
8. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
9. Impact of multicellular resistance on the survival of solid tumors, including micrometastases.
Kerbel RS
Invasion Metastasis; 1994-1995; 14(1-6):50-60. PubMed ID: 7657532
[TBL] [Abstract][Full Text] [Related]
10. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
12. Oncogene transformation and the metastatic phenotype.
Chambers AF; Tuck AB
Anticancer Res; 1988; 8(5A):861-71. PubMed ID: 3052258
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of invasion and metastasis.
Collard JG; Roos E; La Rivière G; Habets GG
Cancer Surv; 1988; 7(4):691-710. PubMed ID: 3072071
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
15. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
[TBL] [Abstract][Full Text] [Related]
16. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
17. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
18. Ras-responsive genes and tumor metastasis.
Chambers AF; Tuck AB
Crit Rev Oncog; 1993; 4(2):95-114. PubMed ID: 8420573
[TBL] [Abstract][Full Text] [Related]
19. [Biology of solid cancers: breast cancer as an example. First part: genetic systems implicated in carcinogenesis].
Bièche I; Lidereau R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):131-41. PubMed ID: 8690861
[TBL] [Abstract][Full Text] [Related]
20. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
